Literature DB >> 26906964

A clinical approach to diagnosis of autoimmune encephalitis.

Francesc Graus1, Maarten J Titulaer2, Ramani Balu3, Susanne Benseler4, Christian G Bien5, Tania Cellucci6, Irene Cortese7, Russell C Dale8, Jeffrey M Gelfand9, Michael Geschwind9, Carol A Glaser10, Jerome Honnorat11, Romana Höftberger12, Takahiro Iizuka13, Sarosh R Irani14, Eric Lancaster3, Frank Leypoldt15, Harald Prüss16, Alexander Rae-Grant17, Markus Reindl18, Myrna R Rosenfeld19, Kevin Rostásy20, Albert Saiz21, Arun Venkatesan22, Angela Vincent14, Klaus-Peter Wandinger23, Patrick Waters14, Josep Dalmau24.   

Abstract

Encephalitis is a severe inflammatory disorder of the brain with many possible causes and a complex differential diagnosis. Advances in autoimmune encephalitis research in the past 10 years have led to the identification of new syndromes and biomarkers that have transformed the diagnostic approach to these disorders. However, existing criteria for autoimmune encephalitis are too reliant on antibody testing and response to immunotherapy, which might delay the diagnosis. We reviewed the literature and gathered the experience of a team of experts with the aims of developing a practical, syndrome-based diagnostic approach to autoimmune encephalitis and providing guidelines to navigate through the differential diagnosis. Because autoantibody test results and response to therapy are not available at disease onset, we based the initial diagnostic approach on neurological assessment and conventional tests that are accessible to most clinicians. Through logical differential diagnosis, levels of evidence for autoimmune encephalitis (possible, probable, or definite) are achieved, which can lead to prompt immunotherapy.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26906964      PMCID: PMC5066574          DOI: 10.1016/S1474-4422(15)00401-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  109 in total

1.  When a serum test overrides the clinical assessment.

Authors:  Thaís Armangue; Joan Santamaria; Josep Dalmau
Journal:  Neurology       Date:  2015-02-27       Impact factor: 9.910

2.  Burden of encephalitis-associated hospitalizations in the United States, 1998-2010.

Authors:  Neil M Vora; Robert C Holman; Jason M Mehal; Claudia A Steiner; Jesse Blanton; James Sejvar
Journal:  Neurology       Date:  2014-01-02       Impact factor: 9.910

3.  A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer.

Authors:  R Voltz; S H Gultekin; M R Rosenfeld; E Gerstner; J Eichen; J B Posner; J Dalmau
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

Review 4.  Primary angiitis of the CNS.

Authors:  Rula A Hajj-Ali; Aneesh B Singhal; Susanne Benseler; Eamonn Molloy; Leonard H Calabrese
Journal:  Lancet Neurol       Date:  2011-06       Impact factor: 44.182

5.  Herpes simplex virus encephalitis is a trigger of brain autoimmunity.

Authors:  Thaís Armangue; Frank Leypoldt; Ignacio Málaga; Miquel Raspall-Chaure; Itxaso Marti; Charles Nichter; John Pugh; Monica Vicente-Rasoamalala; Miguel Lafuente-Hidalgo; Alfons Macaya; Michael Ke; Maarten J Titulaer; Romana Höftberger; Heather Sheriff; Carol Glaser; Josep Dalmau
Journal:  Ann Neurol       Date:  2014-02-25       Impact factor: 10.422

6.  Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.

Authors:  Helena Ariño; Romana Höftberger; Nuria Gresa-Arribas; Eugenia Martínez-Hernández; Thaís Armangue; Michael C Kruer; Javier Arpa; Julio Domingo; Bojan Rojc; Luis Bataller; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

7.  Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.

Authors:  Anna Boronat; Jeffrey M Gelfand; Nuria Gresa-Arribas; Hyo-Young Jeong; Michael Walsh; Kirk Roberts; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Bernardo Rudy; Josep Dalmau
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

Review 8.  Hashimoto's encephalopathy.

Authors:  Nicoline Schiess; Carlos A Pardo
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

9.  Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.

Authors:  Russell C Dale; Vera Merheb; Sekhar Pillai; Dongwei Wang; Laurence Cantrill; Tanya K Murphy; Hilla Ben-Pazi; Sophia Varadkar; Tim D Aumann; Malcolm K Horne; Andrew J Church; Thomas Fath; Fabienne Brilot
Journal:  Brain       Date:  2012-10-11       Impact factor: 13.501

10.  Clinical analysis of anti-Ma2-associated encephalitis.

Authors:  Josep Dalmau; Francesc Graus; Alberto Villarejo; Jerome B Posner; Deborah Blumenthal; Brian Thiessen; Albert Saiz; Patricio Meneses; Myrna R Rosenfeld
Journal:  Brain       Date:  2004-06-23       Impact factor: 13.501

View more
  751 in total

1.  Case Report: Subacute Sclerosing Panencephalitis Presenting as Acute Encephalitis.

Authors:  Ravindra Kumar Garg; Neeraj Kumar; Imran Rizvi; Amita Jain; Ravi Shekhar Jaipuriar; Praveen Kumar Sharma; Hardeep Singh Malhotra; Danish Nasar Khan; Ravi Uniyal
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

2.  Clinical characteristics, treatment and long-term prognosis in patients with anti-NMDAR encephalitis.

Authors:  Pritam Raja; Biswas Shamick; L K Nitish; Vikram Venkappayya Holla; P K Pal; Anita Mahadevan; Priya Treesa Thomas; Bhat Maya; J Saini; H Shantala; M Netravathi
Journal:  Neurol Sci       Date:  2021-03-16       Impact factor: 3.307

Review 3.  Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement.

Authors:  Misako Higashida-Konishi; Keisuke Izumi; Masako Tsukamoto; Hiroaki Ohya; Nozomi Takasugi; Satoshi Hama; Yutaro Hayashi; Mari Ushikubo; Kumiko Akiya; Araki Kazuhiro; Yutaka Okano; Hisaji Oshima
Journal:  Clin Rheumatol       Date:  2020-04-30       Impact factor: 2.980

4.  Neuronal damage and neuroinflammation markers in patients with autoimmune encephalitis and multiple sclerosis.

Authors:  V Fominykh; L Brylev; V Gaskin; R Luzin; A Yakovlev; I Komoltsev; I Belousova; A Rosliakova; A Guekht; N Gulyaeva
Journal:  Metab Brain Dis       Date:  2019-07-02       Impact factor: 3.584

5.  Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis.

Authors:  Qi Huang; Yuan Wu; Rongfa Qin; Xing Wei; Meigang Ma
Journal:  J Neurol       Date:  2016-09-15       Impact factor: 4.849

6.  Influential factors and predictors of anti-N-methyl-D-aspartate receptor encephalitis associated with severity at admission.

Authors:  Xiao-Xue Huang; Shuang Zhang; Lu-Lu Yan; Yao Tang; Jun Wu
Journal:  Neurol Sci       Date:  2021-01-23       Impact factor: 3.307

7.  Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.

Authors:  Makoto Hara; Eugenia Martinez-Hernandez; Helena Ariño; Thais Armangué; Marianna Spatola; Mar Petit-Pedrol; Albert Saiz; Myrna R Rosenfeld; Francesc Graus; Josep Dalmau
Journal:  Neurology       Date:  2018-03-16       Impact factor: 9.910

8.  Hashimoto Encephalopathy as a Complication of Autoimmune Thyroiditis.

Authors:  Alixandria A Fiore; Wilson B Pfeiffer; Syed A A Rizvi; Anais Cortes; Conrad Ziembinski; Ronald Pham; Stephanie Graves; Urvesh Patel
Journal:  Med Princ Pract       Date:  2018-10-24       Impact factor: 1.927

9.  Cost-Effectiveness of Routine Screening for Autoimmune Encephalitis in Patients With First-Episode Psychosis in the United States.

Authors:  Eric L Ross; Jessica E Becker; Jenny J Linnoila; Djøra I Soeteman
Journal:  J Clin Psychiatry       Date:  2020-11-17       Impact factor: 4.384

10.  A case of reversible anti-NMDA-receptor encephalitis: neuropsychological and neuroradiological features.

Authors:  Carlotta Mutti; Federica Barocco; Lucia Zinno; Anna Negrotti; Marco Spallazzi; Giovanni Pavesi; Simona Gardini; Paolo Caffarra
Journal:  Neurol Sci       Date:  2017-09-13       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.